Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Peringkat dalam Saham #29910
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Harga Saham
$1.10
Terakhir disinkronkan: 2023-06-07
Kapitalisasi Pasar
$19.12M
Perubahan (1 hari)
-0.90%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

Harga STSA dengan kapitalisasi pasar B
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
STSA
$1.10
Kapitalisasi pasar dari Satsuma Pharmaceuticals, Inc.(STSA)
Kapitalisasi Pasar: $19.12M
Per August 2026, Satsuma Pharmaceuticals, Inc. memiliki kapitalisasi pasar sebesar $19.12M. Ini menjadikan Satsuma Pharmaceuticals, Inc. sebagai perusahaan 29910th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Satsuma Pharmaceuticals, Inc. dari 2019 hingga 2026
STSA dibandingkan dengan 5 teratas stocks paling populer
Harga STSA Aset B Pasar B Hasil
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$305,274 $19.12M
$5.307T +27,752,060.77%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$261,792 $19.12M
$4.551T +23,799,151.07%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$238,990 $19.12M
$4.154T +21,726,238.19%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$206,440 $19.12M
$3.589T +18,767,150.37%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$160,895 $19.12M
$2.797T +14,626,747.68%